Sogroya
Payments companies reported to CMS as associated with Sogroya. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sogroya, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sogroya
These are the largest totals companies reported as associated with Sogroya. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Anthony Heaney | Los Angeles, CA | Endocrinology, Diabetes & Metabolism | $125,526.30 |
| Gnanagurdasan Prakasam | Sacramento, CA | Pediatric Endocrinology | $123,723.25 |
| Jose Gamez-Godoy | Edinburg, TX | Pediatric Endocrinology | $95,304.94 |
| Joshua Yang | Orlando, FL | Pediatric Endocrinology | $67,901.56 |
| Alicia Romano | Sleepy Hollow, NY | Pediatric Endocrinology | $65,334.02 |
| Sarita George | Mineola, NY | Pediatrics (Nurse Practitioner) | $61,630.71 |
| Quentin Vanmeter | Atlanta, GA | Pediatric Endocrinology | $61,321.37 |
| Aristides Maniatis | Centennial, CO | Pediatric Endocrinology | $57,991.22 |
| Bradley Miller | Minneapolis, MN | Pediatric Endocrinology | $43,615.08 |
| Terri Luetjen | Kansas City, MO | Pediatrics (Nurse Practitioner) | $34,754.52 |
Prescribed Sogroya?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.